News

Newsroom

December 23, 2024 GlobeNewsWire

Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs read more...

December 18, 2024 GlobeNewsWire

Neutrolis Expands Senior Leadership Team to Drive Development of Growing Pipeline of Non-Immunosuppressive Therapies for NET-mediated Autoimmune Diseases read more...